About IJCPCR

ANTIMALARIAL DRUGS FOR PEDIATRICS - PRESCRIBING AND DISPENSING PRACTICES IN INDIA
Article Information
Language
Corres.Author
Email
Accepted Date
File size
No of Downloads
Published by
Full Text
Malaria is India's leading cause of morbidity and mortality. Every year, 14–18 million new cases of malaria are registered in the India. 120,000 people died in India as a result of the conflict the age of 18. More than five years old which the rate is 400–500 per 1,000 inhabitants, and For children under the age of five, the number more than doubles years of age About 1. In 70,000 of these deaths occur in children under % of the population is expected to be affected. Malaria care consumes 1% of GDP representing US$2.2 per capita and 39% of total revenue total health-care spending in the India. Approximately one-third of the budget is allocated to government services a portion of their money to fight malaria. Private spending, mainly on medications, coils, and other similar items 71 percent of the amount is spent on sprays and bed-nets the expenses Irrational prescribing has been proven in studies. Antimalarial medications are widely available in most countries. African countries as an example. The aim of this study was to assess prescribing and dispensing practices of artemether-lumefantrine to pediatrics patients in the public hospitals and private pharmacies. The specific goals were to assess parents awareness and knowledge regarding malaria in children as well as their level of understanding of given instructions. Malaria Rapid Diagnostic Tests (MRDTs) have greatly improved malaria diagnosis in Tanzania since their introduction recently. The current use of MRDT may have aided in effective malaria diagnosis and, as a result, low antibiotic use in this study. This study discovered irrational antimalarial drug dispensing, prescribing, and subsequent improper usage in children. Since Tanzania's anti-malarial drug policy was recently revised, it is recommended that strategies such as creating and disseminating easy-to-follow treatment recommendations, as well as a frequent audit of their implementation, be implemented. In addition, prescribers and medication dispensers should receive ongoing medical and pharmacy education on responsible drug use and evidence-based medicineddd